The onychomycosis market size was valued at USD 4.21 Billion in 2025 in the 7 major markets, driven by the rising prevalence of onychomycosis especially in the geriatric population across the major markets. The market size is anticipated to grow at a CAGR of 5.20% during the forecast period of 2026-2035 to achieve a value of USD 6.99 Billion by 2035.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
5.2%
Value in USD Billion
2026-2035
*this image is indicative*
Nail fungus is a common nail infection that initiates as a white or yellow-brown spot under the tip of the fingernail or toenail. The nail starts discoloring, thickening, and crumbling at the edge as the infection goes deep. Nail fungus is also called onychomycosis. When fungus infects the areas between the toes and the skin of the feet, it's called athlete's foot (tinea pedis).
Developments such as oral antifungal drugs like itraconazole (Sporanox), stimulate new nail growth free of infection, slowly replacing the infected part. Another innovation is medicated nail polish ciclopirox (Penlac) prescribed by healthcare professionals to be used once a day for as long as 6 weeks or more. Additionally, medicated nail cream, more of an antifungal cream such as efinaconazole (Jublia) and tavaborole (Kerydin) also works as effective treatments for this nail condition.
The increasing number of clinical developments to treat onychomycosis is a major trend influencing the market growth. Such developments by key players are boosting the demand for treatment for onychomycosis, further boosting the onychomycosis market growth. The increasing approvals of drugs by regulatory bodies for the treatment of onychomycosis are influencing the market growth as well. The increasing investments by pharmaceutical companies in research and development activities to develop novel therapies are majorly expected to drive market growth as well.
The increasing research and development activities to find new treatments or study existing treatments to find their efficacy while looking for scope for improvement are also responsible for the market growth. For example, a meta-analysis study exhibited the efficacy of terbinafine, posted on Oxford Academic. The study mentioned how the efficacy of treatment with terbinafine increased with the increase in treatment duration which was 12 weeks expanded to 24 weeks.
Global Onychomycosis Market Report and Forecast 2026-2035 offers a detailed analysis of the market based on the following segments:
Market Breakup by Treatment Type
Market Breakup by Type
Market Breakup by Route of Administration
Market Breakup by End User
Market Breakup by Region
The increasing prevalence of onychomycosis is a major factor driving the market growth. The prevalence of onychomycosis is great among older people with certain risk factors such as diabetes and weakened immune systems. The market is also driven by the continuous research and developments by key players in the market to develop effective and innovative treatments coupled with increased investments. The increased number of clinical trials to find the efficacy of antifungal drugs for the treatment of onychomycosis such as terbinafine, itraconazole, and fluconazole is also responsible for the onychomycosis market growth.
The increasing awareness about onychomycosis and its treatment options among patients and healthcare providers which helped the patients to get the condition diagnosed on an early basis and get treated, further increasing the demand for medications in the market. This awareness is greatly expected to further influence the market growth. The widespread availability of improved healthcare infrastructure has also played a vital role in the market growth as people are able to access the healthcare facility nearest to them and get better treatment options.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 4.21 Billion in 2025, driven by the increasing research and development.
The market is anticipated to grow at a CAGR of 5.20% during the forecast period of 2026-2035 and is likely to reach a market value of USD 6.99 Billion by 2035.
The increasing incidence of chronic diseases such as diabetes, onychomycosis, and increasing geriatric population are among major factors driving market growth.
The increasing investments by pharmaceutical companies in research and development activities for the development of new therapies are among the major trends influencing market growth.
The major regions of the market include United States, Japan, EU-4 and the United Kingdom. EU-4 includes Germany, France, Italy, and Spain.
Different types of treatments include drugs, laser therapy, and photodynamic therapy, among others.
There are various kinds of onychomycosis, distal subungual onychomycosis, white superficial onychomycosis, and proximal subungual onychomycosis, among other types.
The different routes of administration are oral and topical.
End users in the market are hospitals, dermatology and podiatry clinics, offline pharmacies, and online stores, among others.
Key players involved in the market are Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Cipla Inc., Bayer AG, Pfizer Inc., Abbott, GSK Plc., Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., and Novartis AG.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment Type |
|
| Breakup by Type |
|
| Breakup by Route of Administration |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share